Pfizer
Utility Patents
Last updated:
List of all Pfizer patents 177 in total
| Status | Patent |
|---|---|
Grant | Utility: Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer Filling date: 13 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Neisseria meningitidis composition and methods thereof Filling date: 13 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Tissue factor pathway inhibitor antibodies and uses thereof Filling date: 13 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Neisseria meningitidis compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Anti-IL-33 antibodies, compositions, methods and uses thereof Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: 3-indol substituted derivatives, pharmaceutical compositions and methods for use Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Method of cell culture Filling date: 13 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Cyclopentane-based modulators of STING (stimulator of interferon genes) Filling date: 13 Sep 2025 Issue date: 21 Jan 2020 |
Grant | Utility: Intermediates and methods for synthesizing calicheamicin derivatives Filling date: 13 Sep 2025 Issue date: 17 Dec 2019 |
Grant | Utility: SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease Filling date: 13 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer Filling date: 13 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Treatment with anti-PCSK9 antibodies Filling date: 13 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Aminopyrimidinyl compounds Filling date: 13 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: FGF23 c-tail fusion proteins Filling date: 13 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Sulfonyl amide derivatives for the treatment of abnormal cell growth Filling date: 13 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Filling date: 13 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Filling date: 13 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Substituted nucleoside derivatives useful as anticancer agents Filling date: 13 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Anti-CXCR4 antibodies and antibody-drug conjugates Filling date: 13 Sep 2025 Issue date: 24 Sep 2019 |
Grant | Utility: Heteroaromatic compounds and their use as dopamine D1 ligands Filling date: 13 Sep 2025 Issue date: 24 Sep 2019 |
Grant | Utility: Crystalline form of lorlatinib free base Filling date: 13 Sep 2025 Issue date: 24 Sep 2019 |
Grant | Utility: Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- ophenyl)urea maleate Filling date: 13 Sep 2025 Issue date: 17 Sep 2019 |
Grant | Utility: Bifunctional cytotoxic agents Filling date: 13 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Bispecific antibodies Filling date: 13 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Glycoconjugation process Filling date: 13 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof Filling date: 13 Sep 2025 Issue date: 20 Aug 2019 |
Grant | Utility: Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Filling date: 13 Sep 2025 Issue date: 13 Aug 2019 |
Showing 150 to 177 of 177 patents.